NASDAQ:IDYA | Free Cash Flow | IDEAYA Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$75.17M$967,000.00-$76.14M
2025-12-31-$90.5M$333,000.00-$90.83M
2025-03-31-$60.34M$1.33M-$61.67M
2024-12-31-$121.66M$1.1M-$122.76M
2024-03-31-$43.81M$1.33M-$45.14M
2023-12-31-$23.75M$838,000.00-$24.59M
2023-03-31-$27.84M$43,000.00-$27.89M
2022-12-31-$23.37M$0.00-$23.37M
2022-03-31-$19.65M$401,000.00-$20.05M
2021-12-31-$16.66M$605,000.00-$17.26M
2021-03-31-$13.72M$1M-$14.73M
2020-12-31-$11.6M$179,000.00-$11.78M
2020-03-31-$9.55M
2019-12-31-$8.71M$216,000.00-$8.92M
2019-03-31-$9.79M$606,000.00-$10.39M
2018-12-31-$7.48M$308,000.00-$7.79M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$71.1M$2.37M-$73.47M
2024-12-31-$247.58M$3.86M-$251.44M
2023-12-31-$115.22M$2.37M-$117.59M
2022-12-31-$87.18M$3.44M-$90.62M
2021-12-31-$55.78M$2.64M-$58.42M
2020-12-31$55.46M$493,000.00$54.97M
2019-12-31-$39.31M$1.35M-$40.67M
2018-12-31-$27.62M$1.71M-$29.33M
2017-12-31-$12.22M$1.76M-$13.98M